Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3.
about
Role of bioactive fatty acids in nonalcoholic fatty liver diseaseFibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan CrosstalkEssential roles of four-carbon backbone chemicals in the control of metabolismRegulation of Ketone Body Metabolism and the Role of PPARαMetformin stimulates FGF21 expression in primary hepatocytes.Dietary regulation of histone acetylases and deacetylases for the prevention of metabolic diseases.VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation.Cubilin expression is monoallelic and epigenetically augmented via PPARs.Effects of sodium butyrate and its synthetic amide derivative on liver inflammation and glucose tolerance in an animal model of steatosis induced by high fat diet.β-hydroxybutyrate: much more than a metaboliteFibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice.Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway.Gut microbiota-associated bile acid deconjugation accelerates hepatic steatosis in ob/ob mice.Molecular targets related to inflammation and insulin resistance and potential interventionsTranscriptional and Chromatin Regulation during Fasting - The Genomic EraInhibition of class I histone deacetylases unveils a mitochondrial signature and enhances oxidative metabolism in skeletal muscle and adipose tissueImproving insulin sensitivity with HDAC inhibitorPotential of probiotics, prebiotics and synbiotics for management of colorectal cancer.Butyrate alleviates metabolic impairments and protects pancreatic β cell function in pregnant mice with obesity.Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23.Mechanistic insight into nuclear receptor-mediated regulation of bile acid metabolism and lipid homeostasis by grape seed procyanidin extract (GSPE).Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus.Silencing of the Fibroblast growth factor 21 gene is an underlying cause of acinar cell injury in mice lacking MIST1.Inhibition of HDAC3 as a strategy for developing novel diabetes therapeutics.FGF21 inhibitor suppresses the proliferation and migration of human umbilical vein endothelial cells through the eNOS/PI3K/AKT pathway.Histone Deacetylase 3 Deletion in Mesenchymal Progenitor Cells Hinders Long Bone Development.Butyrate stimulates adipose lipolysis and mitochondrial oxidative phosphorylation through histone hyperacetylation-associated β3 -adrenergic receptor activation in high-fat diet-induced obese mice.Synthesis of magnolol and honokiol derivatives and their effect against hepatocarcinoma cells.A grape seed procyanidin extract inhibits HDAC activity leading to increased Pparα phosphorylation and target-gene expression.On the potential role of intestinal microbial community in hepatocarcinogenesis in chronic hepatitis B.Potential Synergies of β-Hydroxybutyrate and Butyrate on the Modulation of Metabolism, Inflammation, Cognition, and General Health.Sodium Butyrate Ameliorates Streptozotocin-Induced Type 1 Diabetes in Mice by Inhibiting the HMGB1 ExpressionButyrate Protects Mice Against Methionine-Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels
P2860
Q26739904-62157410-50B3-44AC-8502-8E5A5310B538Q26766528-0B245430-51E6-4D50-B677-118074359CB7Q26795753-4179C32C-BBAD-4646-BED2-F43677E14946Q28073224-EF83AC0D-A8C8-42C3-936B-5F382CD0B519Q29347106-8890C209-F1DB-49E8-9567-84F4DEABD833Q34325308-700FB86F-B909-4C9D-913B-53ABB4A39E89Q34428997-A96F1F2F-C7BC-46CB-B228-C9E4E805CC16Q34774905-091B79BC-6EEB-45C3-B1D4-D1136458E17DQ34827887-EA1805DA-786F-40AE-A619-43C3DD4A0EE5Q35553084-98FEFABC-6C22-40CF-A234-B4351623CBCBQ35648897-56E216FF-1663-4496-8F11-8A61DDF51CA2Q35909717-BFC4DE80-F122-496D-A33B-997C9471B3C5Q35998233-1D755242-DEDE-40DE-BE35-A1E0D6663426Q36294297-FF49087E-0AB0-4D05-A551-248D57082075Q36355517-4A0704A6-6D4D-470D-9593-8B90C0928FB8Q36635336-E32AE5D2-BFB4-42AF-82E3-F05A643A3D7CQ36635360-F7613DDA-F888-4BFC-9155-1869C3F0423EQ36892021-FBBF31B9-11EA-4C5D-AB50-C39990CEA9F8Q37054562-72303F65-14F8-4A22-B96C-48419B26B0EBQ38633258-478A6D70-B896-45F7-A7C5-BC0A773207C9Q38770951-23FA79C2-83CB-46D3-843A-A0FB53C691F2Q38794405-0E0614EC-557F-4AF0-85DB-A0A7E85EE342Q42806569-97323774-4EA8-4F6E-8E2D-AFED6AFA13F4Q46155945-D6661ADB-8862-40B3-8A9E-5598D86FADE1Q47220838-BDD6EF35-F705-4369-8E88-628BA532068AQ47984258-E3C94AB1-8A60-43CE-81F7-32F3816B73ACQ48050870-8F95F52E-0434-415D-87B9-64A482E5C5DCQ48508092-5144A9DC-76E3-49E2-8D65-02CF1C2D4BABQ49513722-73D636D9-E866-4A65-B8D9-0FFD38C0FE8CQ54202324-F7FB043E-894A-4A9E-A6A7-1DB4BF5E15D8Q55114436-6BCC8BDD-782C-4456-A76F-04F5FDA2FCB2Q58556121-2E4D3279-3AB6-43F6-B481-AD09313752CBQ58728222-91F6D8EF-8F09-4616-9D45-EE88634E2D94
P2860
Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Sodium butyrate stimulates exp ...... tion of histone deacetylase 3.
@ast
Sodium butyrate stimulates exp ...... tion of histone deacetylase 3.
@en
type
label
Sodium butyrate stimulates exp ...... tion of histone deacetylase 3.
@ast
Sodium butyrate stimulates exp ...... tion of histone deacetylase 3.
@en
prefLabel
Sodium butyrate stimulates exp ...... tion of histone deacetylase 3.
@ast
Sodium butyrate stimulates exp ...... tion of histone deacetylase 3.
@en
P2093
P2860
P356
P1433
P1476
Sodium butyrate stimulates exp ...... tion of histone deacetylase 3.
@en
P2093
Huating Li
Jianping Ye
Weiping Jia
Zhanguo Gao
P2860
P304
P356
10.2337/DB11-0846
P407
P577
2012-02-14T00:00:00Z